A detailed history of Robertson Stephens Wealth Management, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Robertson Stephens Wealth Management, LLC holds 1,921 shares of CRL stock, worth $297,562. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,921
Previous 8,983 78.62%
Holding current value
$297,562
Previous $1.77 Million 79.99%
% of portfolio
0.01%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

SELL
$178.58 - $220.69 $1.26 Million - $1.56 Million
-7,062 Reduced 78.62%
1,921 $354,000
Q3 2024

Nov 12, 2024

BUY
$187.96 - $245.29 $1.69 Million - $2.2 Million
8,983 New
8,983 $1.77 Million

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $7.88B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Robertson Stephens Wealth Management, LLC Portfolio

Follow Robertson Stephens Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robertson Stephens Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Robertson Stephens Wealth Management, LLC with notifications on news.